enVVeno Medical Corp (NVNO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150K 300K 450K Q1 '18: 272.9K Q2 '18: 317.4K Q3 '18: 331.2K Q4 '18: 186.6K Q1 '19: 186.7K Q2 '19: 103.4K Q3 '19: 61.7K Q4 '19: 31.2K Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Gross Profit TTM

0 70K 140K 210K Q4 '18: 186.6K Q1 '19: 186.7K Q4 '18 Q1 '19

Operating Income TTM

-30M -20M -10M 0 10M 20M 30M Q4 '17: -6.1M Q1 '18: -6.4M Q2 '18: -8.3M Q3 '18: -8M Q4 '18: -7.9M Q1 '19: -8M Q2 '19: -6.8M Q3 '19: -7.2M Q4 '19: -7.7M Q1 '20: -7.6M Q2 '20: -7.2M Q3 '20: -7.3M Q4 '20: -9.1M Q1 '21: -10.4M Q2 '21: -11.3M Q3 '21: -12.1M Q4 '21: -16.9M Q1 '22: -19.4M Q2 '22: -24M Q3 '22: -27.5M Q4 '22: -24.9M Q1 '23: -26.4M Q2 '23: -26.2M Q3 '23: -25.4M Q4 '23: -25.2M Q1 '24: -23.9M Q2 '24: -22.6M Q3 '24: -23.4M Q4 '24: -23.8M Q1 '25: -23.3M Q2 '25: -24.9M Q3 '25: -23.6M Q4 '25: -20.9M Q1 '26: -20M Q2 '26: -16.8M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-30M -20M -10M 0 10M 20M 30M Q4 '17: -7.8M Q1 '18: -11.4M Q2 '18: -15.2M Q3 '18: -14.4M Q4 '18: -13M Q1 '19: -9.9M Q2 '19: -6.8M Q3 '19: -7.1M Q4 '19: -7.6M Q1 '20: -7.2M Q2 '20: -6.9M Q3 '20: -7.1M Q4 '20: -9.1M Q1 '21: -10.7M Q2 '21: -11.5M Q3 '21: -11.9M Q4 '21: -16.5M Q1 '22: -19.1M Q2 '22: -23.8M Q3 '22: -27.5M Q4 '22: -24.7M Q1 '23: -25.7M Q2 '23: -25.1M Q3 '23: -24M Q4 '23: -23.5M Q1 '24: -22.1M Q2 '24: -20.6M Q3 '24: -21.2M Q4 '24: -21.8M Q1 '25: -21.3M Q2 '25: -23.1M Q3 '25: -22M Q4 '25: -19.5M Q1 '26: -18.8M Q2 '26: -15.7M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q2 '18: -5.6M Q3 '18: -6.2M Q4 '18: -6.4M Q1 '19: -6.2M Q2 '19: -6.1M Q3 '19: -5.7M Q4 '19: -5.9M Q1 '20: -5.6M Q2 '20: -5.4M Q3 '20: -6.7M Q4 '20: -7.7M Q1 '21: -10.4M Q2 '21: -11.7M Q3 '21: -11.4M Q4 '21: -11.8M Q1 '22: -11.3M Q2 '22: -12.6M Q3 '22: -14.9M Q4 '22: -15.6M Q1 '23: -17.4M Q2 '23: -18M Q3 '23: -17.7M Q4 '23: -18.9M Q1 '24: -17.3M Q2 '24: -16.6M Q3 '24: -16.7M Q4 '24: -16.8M Q1 '25: -17.3M Q2 '25: -17.1M Q3 '25: -17.2M Q4 '25: -15.6M Q1 '26: -14.8M Q2 '26: -14.6M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '19: -6.1M Q4 '19: -6.3M Q1 '20: -5.9M Q2 '20: -5.8M Q3 '20: -6.9M Q4 '20: -7.9M Q1 '21: -10.6M Q2 '21: -11.9M Q3 '21: -11.7M Q4 '21: -12.2M Q1 '22: -11.7M Q2 '22: -12.9M Q3 '22: -15M Q4 '22: -15.7M Q1 '23: -17.5M Q2 '23: -18.1M Q3 '23: -17.8M Q4 '23: -18.9M Q1 '24: -17.3M Q2 '24: -16.7M Q3 '24: -16.7M Q4 '24: -16.9M Q3 '19 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q2 '21: 8.5K Q3 '21: 9.2M Q1 '22: 11.2M Q2 '22: 11.2M Q3 '22: 11.2M Q1 '23: 11.2M Q2 '23: 11.2M Q3 '23: 11.2M Q1 '24: 16.1M Q2 '24: 16.1M Q3 '24: 16.1M Q1 '25: 581K Q2 '25: 581K Q3 '25: 20.2M Q1 '26: 654K Q2 '26: 671K Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '17: -1.35 Q1 '18: -1.94 Q2 '18: -2.78 Q3 '18: -2.52 Q4 '18: -1.75 Q1 '19: -1.08 Q2 '19: -0.15 Q3 '19: -0.12 Q4 '19: -12.11 Q1 '20: -13.55 Q2 '20: -15.31 Q3 '20: -16.59 Q4 '20: -7.68 Q1 '21: -6.59 Q2 '22: -2.30 Q3 '22: -2.58 Q4 '22: -2.19 Q1 '23: -2.29 Q2 '23: -2.24 Q3 '23: -2.15 Q4 '23: -1.92 Q1 '24: -1.66 Q2 '24: -1.39 Q3 '24: -1.29 Q4 '24: -44.53 Q1 '25: -51.97 Q2 '25: -63.18 Q3 '25: -63.06 Q4 '25: -51.78 Q1 '26: -49.92 Q2 '26: -43.77 Q2 '18 Q2 '19 Q2 '20 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.